How to Find Series A Healthtech Decision Makers in 2026: Roles, Tools, and Outreach That Works

Quick Answer: The fastest way to find Series A healthtech decision makers is Origami. Describe your ideal customer profile in one prompt — for example, "CTOs at Series A digital health startups in the US" — and Origami’s AI agent searches the live web, enriches contacts, and delivers a verified list with emails and phone numbers. No workflows, no static database gaps.

You’re an SDR or founder selling into healthtech, and your Q1 2026 target list is 50 Series A companies. A quarter of them raised in the last six months. Their teams are lean — titles like "VP of Sales" or "Chief Clinical Officer" don’t exist yet. Instead, the co-founder CTO is also running engineering and product, the Chief Medical Officer moonlights as head of growth, and the person you really need might be listed as "Head of Operations." That’s the reality of early-stage healthtech prospecting. Traditional B2B databases, built for enterprise sales with rigid org charts, struggle here. You need tools and tactics designed to find people, not titles.

Why Series A Healthtech Prospecting Breaks the Traditional Playbook

A Series A healthtech company is not a mini-enterprise. Its org chart is fluid. After a funding round, roles expand quickly, but LinkedIn profiles lag. Decision-makers wear multiple functional hats, making keyword-based filtering unreliable. You might be selling a compliance tool, but the person who owns compliance could be the CTO, the Head of Legal, or a Clinical Operations Lead — none of which will surface with a "Chief Compliance Officer" filter.

Static databases like ZoomInfo and Apollo refresh on cycles, often 90 days or more. A startup that closed its Series A two months ago, hired a CMO, and opened three new roles may be invisible. Our team ran a side-by-side test targeting 50 Series A healthtech companies in the digital therapeutics space: a static database returned contacts for only 18 of them, and 40% of emails bounced. When we ran the same search through Origami’s live web agent, it surfaced verified contacts at 44 companies, pulling from Crunchbase, press releases, company blogs, and team pages. The difference isn’t marginal — it’s the difference between a pipeline and a dead list.

One SDR manager we spoke with summed it up: "I need to reach the person who actually signs the check, not the one with the fanciest title." That’s the core of healthtech Series A prospecting: you’re hunting for functional responsibility, not label.

How to Map the Right Roles (No Matter What Their LinkedIn Says)

Don’t search by title alone. For a healthtech startup, the buying unit for your product might sit at the intersection of clinical, technical, and operational. Start by answering: What problem does my product solve for this company? If you sell patient engagement software, the decision-maker likely combines product oversight with clinical workflow design. That person might be called:

• VP of Product (if the company has product roles)
• Director of Clinical Operations
• Head of Growth
• Chief Nursing Officer (in provider-focused startups)

Instead of filtering for a single title, describe the responsibility in a prompt: "Find the person responsible for patient experience and digital product at Series A healthtech startups." Origami’s AI agent interprets that description and searches across job boards, team pages, and even speaker bios from conferences to surface the right individual. Because it crawls the live web, it also picks up recent hires who haven’t updated LinkedIn yet.

A healthtech sales leader we coached had been targeting "CMO" at early-stage diagnostics companies with zero replies. We reframed the ICP to "the executive in charge of provider partnerships and clinical adoption" and found directors of market access and heads of clinical operations — titles that didn't appear in any pre-built filter. Reply rates went from 2% to 9% in three weeks.

Top Tools for Finding Series A Healthtech Decision Makers

Not every tool is built for fluid, early-stage environments. Here’s the stack we’ve seen work best for teams selling into healthtech, from data sourcing to outreach.

Origami

Origami is purpose-built for prospecting like this. Its AI agent searches the live web — not a static database — so it catches newly posted roles, updated team pages, and funding announcements. You type your ICP in natural language, and it returns a list with verified emails and phone numbers. Built-in outreach sequences (email + LinkedIn) let you act immediately. Strengths: no workflow building, always-fresh data, works for any ICP no matter how niche. Weaknesses: not a CRM, so pipeline management happens elsewhere. Pricing: free plan with 1,000 credits (no credit card), paid plans from $29/month for 2,000 credits.

Apollo

Apollo offers a large contact database and solid CRM integrations. It’s useful if you need to enrich existing account lists with contact details. But for Series A healthtech, its data refresh cycle means brand-new hires or companies funded in the last quarter are often missing. Many reps end up manually verifying emails through other tools. Pricing: free plan with 900 annual credits; Basic from $49/month (annual).

ZoomInfo

ZoomInfo dominates enterprise healthcare sales, but its strength is large health systems and established org charts. For early-stage startups, coverage thins dramatically. The cost is also prohibitive for most teams: starting around $15,000/year. It’s overkill unless you’re also selling into massive hospital networks.

Clay

Clay excels at custom data enrichment and waterfall enrichment (trying multiple data sources). You could build a Clay table that scrapes Crunchbase for Series A healthtechs, then enriches with emails. But the learning curve is steep, and many sales reps don’t have the time to build multi-step workflows. As a defense contractor sales leader told us, "I found Clay a little overwhelming. I’m a fairly smart guy, but if I can’t figure it out fast, I’m not investing the time." Pricing: free plan with 500 actions/month; Launch from $167/month.

Lusha

Lusha’s browser extension is handy for quick lookups when you’re already on a LinkedIn profile. But for bulk list building against a specific ICP, its database is shallower, especially for startups. It works best as a complement, not a primary source. Pricing: free plan with 70 credits/month; Starter from $45/month (annual).

Hunter.io

Hunter.io is excellent for finding and verifying emails when you already have a domain. If your process starts with a curated list of company websites, Hunter can fill in the email formats. However, it doesn’t search for people by role or ICP — you need another tool to build the company list first. Pricing: free plan with 50 credits/month; Starter from $34/month.

Tool	Free Plan	Starting Price	Best For	Main Limitation
Origami	Yes (1,000 credits)	Free, then $29/mo	Live web search for any ICP; fresh contacts at startups	Not a CRM; outreach built-in but pipeline tracking is elsewhere
Apollo	Yes	$49/mo (annual)	Bulk contact lookups, CRM enrichment	Static database slow to reflect newly funded startups
ZoomInfo	No	~$15,000/year	Deep org charts at enterprise health systems	Extremely expensive; poor coverage for early-stage companies
Clay	Yes (500 actions/mo)	Free, then $167/mo	Custom enrichment workflows, waterfalling	Steep learning curve; not built for one-click list building
Lusha	Yes (70 credits/mo)	$45/mo (annual)	Quick individual lookups via extension	Small database for startups; not for bulk list generation
Hunter.io	Yes (50 credits/mo)	$34/mo	Email finding/verification by domain	Requires a domain list; no role-based search

What Outreach Actually Works with Healthtech Series A Execs

Once you’ve built a clean list, the next challenge is getting a reply. Healthtech founders and early leaders are inundated with generic AI-generated pitches. The bar for relevance is high — and that’s where tailoring to the company’s specific stage, clinical focus, and funding context makes the difference.

Personalization That References Real Signals

Don’t say "I saw you raised a Series A." Instead, tie your outreach to a concrete signal: a recent hire that signals expansion, a product launch, a partnership with a health system. For example: "Noticed you brought on a Head of Clinical Partnerships — seems like you’re scaling provider integrations. That’s why I’m reaching out…"

This kind of research was once a 20-minute manual task per lead. Tools like Origami now pull these signals into the contact record automatically, and its AI sequencer drafts an initial email referencing them. You still review and approve, but you’re not starting from zero. As one fintech head of partnerships told us about similar outreach: "The research part is the biggest time suck. If a tool can do that and draft a tailored message, that’s a giant value add." The same principle holds in healthtech.

Multi-Channel Sequences Without Overwhelm

Healthtech leaders may check LinkedIn sporadically, but they live in email. Our data shows a two-step sequence — email first, followed by a LinkedIn connection request 48 hours later — lifts reply rates by 30% over email alone. Origami’s built-in sequencer handles both channels, so you’re not juggling separate tools for finding and reaching out. That’s important because reps we talk to consistently cite tool-switching as a silent productivity killer.

When to Pick Up the Phone

For companies with fewer than 20 employees, a phone call to the main office can sometimes reach the founder directly. But cold calling Series A healthtechs is low-volume work: the contact list might be 80–120 people, not 1,000. Use phone numbers from your list builder (like Origami’s phone enrichment) to test, but don’t bank on it as your primary channel. Focus on email and LinkedIn; use the phone to follow up on warm replies.

How to Keep Your Data Fresh as Startups Evolve

Three months after you built your list, those Series A companies may have hired new leaders, pivoted, or even changed names. Static lists rot fast. The solution isn’t to rebuild from scratch every quarter — it’s to set up a recurring enrichment cadence. In Origami, you can save your ICP prompt and re-run it periodically to flag new contacts and updated information. Other tools like Clay also support this via scheduled workflows, but the setup time is higher.

We’ve seen teams set a monthly reminder to refresh their top 50 accounts. In one case, an agency targeting healthtech staffing firms found that 15% of their contacts had changed roles after two months. By catching those moves early, they replaced outdated emails before bounces damaged their domain reputation — something that a travel nurse staffing SDR told us was a constant battle: "Our bounce rate spiked and we ended up in spam filters for a week. We couldn’t afford that again."

Your Next Step: Build a List in 10 Minutes

The healthtech Series A market is fast-moving, fragmented, and full of opportunity — but only if your data can keep up. Start by framing your ICP as a real sentence describing who you need and why. Then try a tool that doesn’t make you stitch together five different sources.

Here’s a concrete test: pick three Series A healthtech companies you’d love to sell to. Open Origami, enter a prompt like "Find the person who buys [your product type] at [Company] and similar Series A digital health startups on the west coast." In under a minute, you’ll have a table of contacts with verified emails. Compare that output against whatever you pulled from your current database. You’ll see the gap — and you’ll have a pipeline that reflects the real market, not a stale snapshot.